chlamydia News
-
Evofem Biosciences to Present at H.C. Wainwright BioConnect Conference
SAN DIEGO, Jan. 4, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that the Company will present and host one-on-one meetings at the H.C. Wainwright BioConnect Virtual Conference being held from January 10 – 13, 2022. Chief Executive Officer Saundra Pelletier will provide an update on the commercialization of Evofem's hormone-free contraceptive Phexxi® ...
-
Abbott Molecular distribution of ELITechGroup products will expand distribution channels
ELITechGroup today announced a distribution agreement with Abbott Molecular, Inc. for U.S. distribution of molecular diagnostic reagents. The reagents included in the agreement are focused on monitoring virus activity in patients that have undergone organ or hematopoietic stem cell transplantation. Other products included in the agreement will focus on the expanding need to test for additional ...
By ELITechGroup
-
Evofem Biosciences to Report Fourth Quarter and Year-End 2021 Results and Provide Corporate Update on Thursday, March 3, 2022
SAN DIEGO, Feb. 17, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) will hold a webcast and conference call to discuss financial results and business highlights for the fourth quarter and year ended December 31, 2021 on Thursday, March 3, 2022 at 4:30 p.m. ET (1:30 p.m. PT). The webcast (live and archived) and related slide presentation can be accessed through ...
-
Evofem Biosciences to Adjourn Special Meeting of Stockholders on December 8, 2021
SAN DIEGO, Dec. 8, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that it intends to adjourn, without conducting any business, its 2021 special meeting of stockholders (the "Special Meeting") scheduled to occur at 8:00 a.m. PST on December 8, 2021, and reconvene at 8:00 a.m. PST on December 15, 2021, to vote on the proposal described in the proxy statement filed with ...
-
Psittacosis and Chlamydia psittaci Exposed in New Online Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of another online video to help educate the public about environmental issues that may impact their health. The latest educational video discusses psittacosis and Chlamydia psittaci. Psittacosis is an infectious disease usually transmitted to humans from birds in the parrot family as well as from turkeys and ...
-
Chiricahua Community Health Centers, Inc., Launches STI Testing Program for Women with Same-Day Results
The Body Agency Collective, Visby Medical, Inc. and CCHCI observe National STD Awareness Month with women’s health initiative on US-Mexico border. CCHCI among first healthcare providers in the nation to adopt new handheld PCR technology to detect gonorrhea, chlamydia and trichomoniasis in a single visit. Chiricahua Community Health Centers, Inc. (CCHCI) today announced a collaboration ...
-
Evofem Biosciences Expects Record High Phexxi Prescriptions and Strong Net Revenue Growth in Fourth Quarter 2021
SAN DIEGO, Dec. 9, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced bullish expectations for prescription and net revenue growth in the fourth quarter of 2021. Total monthly prescriptions (TRx) of Phexxi® (lactic acid, citric acid and potassium bitartrate) are on track to surpass 30,000 in the fourth quarter of 2021, representing approximately 70% growth from ...
-
Evofem Biosciences Announces Record Net Sales and Phexxi Prescriptions in Q4 2021
Net product revenue more than doubled in the fourth quarter of 2021 vs. third quarter of 2021 81% increase in Phexxi units dispensed 69% increase in total prescriptions of Phexxi Net cash burn decreased to $17 million SAN DIEGO, Jan. 19, 2022 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced strong preliminary results for the fourth quarter of 2021, including record ...
-
Phexxi Access to Expand under New Government Guidance Stating Insurers Must Cover FDA-approved Contraceptives with No Out-of-Pocket Costs to Women
SAN DIEGO, Jan. 12, 2022 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today commended the Health Resources and Services Administration (HRSA) and the U.S. Department of Labor on their separately-issued updated guidance related to contraceptive access. The new guidance specifies that most insurers and pharmacy benefit managers (PBMs) must provide coverage, with no out-of-pocket costs ...
-
Evofem Biosciences and Orion Biotechnology Launch Collaboration to Develop MPT Product Candidate to Include HIV Prevention
SAN DIEGO, Dec. 16, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) and Orion Biotechnology Canada Ltd. today announced that they have entered into a collaboration agreement to evaluate the compatibility and stability of Orion's novel CCR5 antagonist, OB-002, in Evofem's Phexxi® (lactic acid, citric acid and potassium bitartrate) vaginal gel with the goal of developing a ...
-
Urgent Care For Children Collaborates With Visby Medical To Provide New Gold Standard Diagnostic For Sexually Transmitted Infections
Visby Medical, Inc. an innovative diagnostic company, today announced its agreement with Urgent Care for Children (UC4C) to offer the company’s new Sexual Health Click Test to patients for the detection of sexually transmitted infections (STIs) in female patients 14 years of age and older. The device can detect chlamydia, gonorrhea, and trichomoniasis, three of the most common and curable ...
-
Clinical Data of The Visby Medical Sexual Health Click Test Published in Journal of the American Sexually Transmitted Diseases Association
Visby Medical™, a leading medical diagnostic company, today announced results from the cross-sectional single visit patient outcomes and implementation study, which evaluated self-collected vaginal swab samples from 55 women using the Visby Medical Sexual Health Click Test for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV). The results of this ...
-
Newly Disclosed Documents Show FDA Allows Livestock Antibiotics Use Despite “High Risk” to Humans`
The Food and Drug Administration (FDA) quietly allowed 30 potentially harmful antibiotics, including 18 rated as "high risk," to remain on the market as additives in farm animal feed and water – despite an internal review that raised significant red flags, according to agency records obtained by the Natural Resources Defense Council (NRDC). The data show the use of these drugs in livestock ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you